HIV Archives – Page 23 of 90 – Treatment Action Group

The Antiretroviral Pipeline

October 10, 2018
Chad Cipiti

July 2018 by Tim Horn The past 12 months has been historic in terms of the number of new HIV treatment modalities reaching pharmacy shelves, at least in the United States. Four originator products – the first dual-drug regimen for…

The HIV PrEP and Microbicides Pipeline

October 10, 2018
Chad Cipiti

July 2018 by Jeremiah Johnson Since 2011, HIV prevention has undergone a true revolution. With three major studies (HPTN 052, PARTNER, and Opposites Attract) now showing zero new infections linked to an HIV positive person who has successfully suppressed their…

The HIV Vaccines, Passive Immunization, and Antibody Gene Transfer Pipeline

October 10, 2018
Chad Cipiti

July 2018 by Richard Jefferys The most important news in preventive HIV vaccine research over the past year is the opening of a Phase IIb trial testing the efficacy of a prime-boost approach developed by Janssen Vaccines & Prevention B.V.,…

TAG Cofounder Gregg Gonsalves Receives 2018 MacArthur Fellowship

October 4, 2018
Chad Cipiti

Treatment Action Group congratulates TAG cofounder and Yale University Assistant Professor Gregg Gonsalves on receiving a 2018 MacArthur Fellowship. Gregg co-wrote TAG’s seminal 1992 report, “AIDS Research at the NIH: A Critical Review” with Mark Harrington and wrote the crucial 1993 report “Basic Science on HIV Infection: A Report from the Front.”

Migrants’ Inclusion Central to Achieving HIV and Hepatitis C Targets by 2030

July 26, 2018
Chad Cipiti

The European African Treatment Advocates Network (EATAN), in partnership with Treatment Action Group (TAG) and other migrant-focused organizations, hosted the European African HIV & Hepatitis C Virus (HCV) Community Summit 2018.

Activists Call on Countries and Donors to Immediately Scale Up Use of Life-Saving TB LAM Test

July 22, 2018
Chad Cipiti

At the TB 2018 pre-conference held on Sunday 22 July 2018, before the International AIDS Conference in Amsterdam, activists from around the globe called on their countries, development partners, and donors, to end the unacceptable death rates caused by TB in people living with HIV by immediately scaling up the use of TB LAM testing.

White House and Congress Must Boldly Address Drug Pricing and Ensure Access to Critical HIV, HCV, and TB Medications

July 16, 2018
Chad Cipiti

Treatment Action Group (TAG), NASTAD (National Alliance of State & Territorial AIDS Directors) and HIVMA (HIV Medicine Association join together in submitting collaborative comments today in response to the Department of Health and Human Services (HHS) public request for information (RFI) on the agency’s Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.

Mark Harrington of TAG and Dr. Demetre Daskalakis of NYC Health Dept. Respond to NY Times Opinion Piece About PrEP

July 6, 2018
Chad Cipiti

Read Mark and Demetre's response to The New York Times June 26 opinion piece, "The End of Safe Gay Sex?"

Ending the Epidemic – Building Effective Collaboration between Community Advocates and Health Departments

May 14, 2018
Chad Cipiti

Ending the Epidemic: Building Effective Collaboration between Community Advocates and Health Departments, presented by Treatment Action Group and Housing Works, May 31, 2018 Since 2014, community-led Ending the Epidemic (EtE) initiatives have advanced across the nation, setting ambitious targets to…

Ending the Epidemic–Update on Implementing the New York State Blueprint

April 23, 2018
Chad Cipiti

In 2014, Governor Andrew Cuomo backed a community advocated plan to aggressively scale up testing, linkage to treatment, and PrEP access in order to dramatically reduce new infections below epidemic levels by the year 2020. The good news is that…